Charles Schwab’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55.4K | Sell |
133,433
-77,618
| -37% | -$32.2K | ﹤0.01% | 3445 |
|
|
2025
Q1 | $131K | Sell |
211,051
-5,656
| -3% | -$3.52K | ﹤0.01% | 3303 |
|
|
2024
Q4 | $362K | Sell |
216,707
-8,595
| -4% | -$14.4K | ﹤0.01% | 3232 |
|
|
2024
Q3 | $410K | Sell |
225,302
-10,718
| -5% | -$19.5K | ﹤0.01% | 3213 |
|
|
2024
Q2 | $1.42M | Buy |
236,020
+26,261
| +13% | +$158K | ﹤0.01% | 2807 |
|
|
2024
Q1 | $2.34M | Buy |
209,759
+1,595
| +0.8% | +$17.8K | ﹤0.01% | 2544 |
|
|
2023
Q4 | $3.1M | Buy |
208,164
+67,430
| +48% | +$1M | ﹤0.01% | 2498 |
|
|
2023
Q3 | $676K | Sell |
140,734
-24,817
| -15% | -$119K | ﹤0.01% | 2933 |
|
|
2023
Q2 | $1.24M | Buy |
165,551
+15,079
| +10% | +$113K | ﹤0.01% | 2696 |
|
|
2023
Q1 | $680K | Sell |
150,472
-9,513
| -6% | -$43K | ﹤0.01% | 2852 |
|
|
2022
Q4 | $1.8M | Buy |
159,985
+8,483
| +6% | +$95.6K | ﹤0.01% | 2600 |
|
|
2022
Q3 | $1.45M | Sell |
151,502
-211
| -0.1% | -$2.02K | ﹤0.01% | 2679 |
|
|
2022
Q2 | $1.23M | Buy |
151,713
+18,234
| +14% | +$148K | ﹤0.01% | 2718 |
|
|
2022
Q1 | $2.26M | Sell |
133,479
-6,403
| -5% | -$108K | ﹤0.01% | 2605 |
|
|
2021
Q4 | $3.01M | Buy |
139,882
+1,176
| +0.8% | +$25.3K | ﹤0.01% | 2569 |
|
|
2021
Q3 | $10.2M | Buy |
138,706
+46,002
| +50% | +$3.4M | ﹤0.01% | 1994 |
|
|
2021
Q2 | $5.07M | Buy |
92,704
+1,734
| +2% | +$94.8K | ﹤0.01% | 2348 |
|
|
2021
Q1 | $6.71M | Buy |
90,970
+18,939
| +26% | +$1.4M | ﹤0.01% | 2155 |
|
|
2020
Q4 | $6.21M | Buy |
72,031
+14,107
| +24% | +$1.22M | ﹤0.01% | 2112 |
|
|
2020
Q3 | $2.19M | Buy |
+57,924
| New | +$2.19M | ﹤0.01% | 2463 |
|